![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/18 | (2006.01) |
C07K 16/18 | (2013.01) | ||
C07K 16/40 | (2006.01) | ||
C07K 16/40 | (2013.01) | ||
A61K 39/395 | (2006.01) | ||
C07K2317/24 | (2013.01) | ||
A61P 7/00 | (2006.01) | ||
C07K2317/76 | (2013.01) | ||
C07K2317/94 | (2013.01) | ||
A61K2039/505 | (2013.01) | ||
A61K2039/54 | (2013.01) | ||
A61K2039/545 | (2013.01) | ||
A61P 7/00 | (2018.01) |
(11) | Number of the document | 3802593 |
(13) | Kind of document | T |
(96) | European patent application number | 19731444.6 |
Date of filing the European patent application | 2019-05-29 | |
(97) | Date of publication of the European application | 2021-04-14 |
(45) | Date of publication and mention of the grant of the patent | 2024-09-11 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2019/034293 |
Date | 2019-05-29 |
(87) | Number | WO 2019/231983 |
Date | 2019-12-05 |
(30) | Number | Date | Country code |
201862678455 P | 2018-05-31 | US |
(72) |
PAYTON, Lori , US
ROTTINGHAUS, Scott T. , US
PRADHAN, Rajendra , US
ORTIZ, Stephan , US
OGAWA, Masayo , US
GAO, Xiang , US
|
(73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
(54) | DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS |
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) IN PEDIATRIC PATIENTS |